This is a Clinical Research Study to evaluate the efficacy, safety, and tolerability of an extended-release investigational drug in adult patients with Schizophrenia.
Are you or a loved one diagnosed with Schizophrenia for more than 1 year?
Segal Trials is currently conducting a clinical research study evaluating the safety and efficacy of an investigational medication for patients with Schizophrenia.
- Volunteer must be between the ages of 18-64 years old
- Volunteer must be diagnosed with Schizophrenia for more than 1 year
- Volunteer must have experienced hallucinations, unusual thoughts, or paranoid
- Volunteer would benefit from psychiatric hospitalization
- Study length: up to 56 weeks